Panel Narrowly Recommends Medtronic Spine Treatment After Tough Scrutiny

An FDA advisory panel cast a mixed vote on July 27 in support of Medtronic's Amplify rhBMP-2 Matrix spinal treatment, reflecting disagreement about safety and the reliability of some clinical data